- Home
- REAL vs ELVN Comparison
REAL vs ELVN Comparison
Compare REAL & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REAL | ELVN |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | REAL | ELVN |
|---|---|---|
| Price | $11.69 | $29.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $17.00 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 3.4M | 625.8K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.55 | 5.97 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $692,845,000.00 | N/A |
| Revenue This Year | $12.55 | N/A |
| Revenue Next Year | $9.46 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.38 | N/A |
| 52 Week Low | $4.61 | $13.30 |
| 52 Week High | $17.39 | $30.22 |
Technical Indicators
Market Signals| Indicator | REAL | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 41.31 | 64.16 |
| Support Level | $10.52 | $18.41 |
| Resistance Level | $12.84 | $29.63 |
| Average True Range (ATR) | 0.84 | 1.36 |
| MACD | 0.16 | 0.05 |
| Stochastic Oscillator | 37.24 | 85.44 |
Price Performance
Historical ComparisonAbout REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.